Edwards Lifesciences EBITDA 2010-2024 | EW

Edwards Lifesciences EBITDA for the quarter ending September 30, 2024 was $0.385B, a 4.39% decline year-over-year.

  • Edwards Lifesciences 2023 EBITDA was 1.679B, a 11.07% decline from 2022.
  • Edwards Lifesciences 2022 EBITDA was 1.888B, a 3.45% increase from 2021.
  • Edwards Lifesciences 2021 EBITDA was 1.825B, a 81.64% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Edwards Lifesciences EBITDA 2010-2024 | EW

  • Edwards Lifesciences 2023 EBITDA was 1.679B, a 11.07% decline from 2022.
  • Edwards Lifesciences 2022 EBITDA was 1.888B, a 3.45% increase from 2021.
  • Edwards Lifesciences 2021 EBITDA was 1.825B, a 81.64% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.